Berrin Monteleone, MD
Clinical Genetics (M.D.) · Mineola, NYNPI 1972765220
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $31,173 of the $50,228 with a category attached, or 62.1%. PTC Therapeutics, Inc. accounts for 66.1% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $19,200 and has fallen 97.8% since, to $431 in 2025. Among clinical genetics (m.d.) clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $772.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- PTC Therapeutics, Inc.$33K
- AstraZeneca$7K
- Acadia Pharmaceuticals Inc$4K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Akcea Therapeutics, Inc.$2K
- Sanofi$486
- plus $743 from 7 others
Across 13 payments — averaging $7375.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$64K
- Akcea Therapeutics, Inc.$32K
What the payments were for
- Consulting fees$31,17362%
- Speaking & faculty fees$15,54131%
- Travel & lodging$1,5923%
- Food & beverage$1,9214%
- Education$20%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| PTC Therapeutics, Inc. | 28 | $33,204 |
| AstraZeneca | 9 | $7,410 |
| Acadia Pharmaceuticals Inc | 2 | $4,168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $2,450 |
| Akcea Therapeutics, Inc. | 2 | $1,767 |
| Sanofi | 7 | $486 |
| Chiesi USA, Inc. | 2 | $227 |
| Alnylam Pharmaceuticals Inc. | 4 | $180 |
| Sobi, Inc | 1 | $150 |
| Biogen | 1 | $125 |
| Amryt Pharma Holdings Ltd | 1 | $26 |
| Travere Therapeutics, Inc. | 3 | $20 |
| Genentech USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$50,228 in reported general payments places this provider in the 90th percentile of 49 clinical genetics (m.d.) providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical genetics (m.d.) in Mineola
- Robert DesnickNew York$207K
- Manisha BalwaniNew York$188K
- David KronnValhalla$135K
- Jaya GaneshNew York$65K
- George DiazNew York$44K
- Christopher CunniffNew York$25K
- David BeckNew York$21K
- Kimihiko OishiNew York$15K
- Mary LopiccoloNew York$13K
- Margo BreilynBronx$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.